Diagnostic Tests – Factor V Leiden Mutation

1. What Is Factor V Leiden?


Factor V Leiden is a genetic mutation that makes Factor V resistant to the inhibitory action of activated protein C (APC), one of the body’s natural anticoagulants. Normally, protein C slows the clotting cascade by inactivating Factor V; however, the Factor V Leiden mutation alters the structure of Factor V so that it no longer responds effectively to protein C. As a result, clotting continues unchecked, creating a hypercoagulable state. This condition is the most common inherited thrombophilia, significantly increasing a person’s risk of developing venous thromboembolism (VTE) such as deep vein thrombosis (DVT) or pulmonary embolism (PE).


2. When Do You Answer Factor V Leiden Mutation Testing?

Testing for the Factor V Leiden mutation is indicated in young patients who present with an unprovoked DVT or PE, especially when the event occurs without clear provoking factors such as recent surgery, trauma, or immobilization. Board-style scenarios often feature:

• A first-time clot in a young adult
• A thrombotic event after a long airplane flight or prolonged immobility
• A family history of recurrent clots

In these cases, Factor V Leiden testing is the most accurate test for identifying a hereditary cause of hypercoagulability. It is part of the evaluation when considering inherited thrombophilias.


3. What Other Tests Should Be Sent With It?

When evaluating a patient for possible inherited or acquired hypercoagulable states, several additional tests are typically ordered alongside Factor V Leiden. These include:

• Protein S levels – Low levels increase clotting risk.
• Protein C levels – Especially important when the case mentions skin necrosis, which may occur when patients with undiagnosed protein C deficiency receive warfarin.
• Lupus anticoagulant testing – Consider this when the patient has an unexplained prolonged PTT, recurrent spontaneous abortions, or autoimmune features; this suggests antiphospholipid syndrome.
• Antithrombin III deficiency testing – Suspect this when a patient shows resistance to heparin, as AT III is required for heparin’s anticoagulant effect.

Together, these tests help create a comprehensive picture of a patient’s thrombotic risk and identify whether the cause is inherited, acquired, or multifactorial.






​

Diagnostic Tests – Haptoglobin Levels


1. What Is Haptoglobin?

Haptoglobin is a plasma protein that binds freely circulating hemoglobin released from red blood cells during hemolysis. Under normal conditions, haptoglobin levels remain stable because little free hemoglobin circulates in the bloodstream. However, when red blood cells rupture—whether due to immune destruction, mechanical trauma, or inherited hemolytic disorders—large amounts of hemoglobin spill into the plasma. Haptoglobin binds this hemoglobin, forming complexes that are removed from circulation by the reticuloendothelial system. As a result, serum haptoglobin levels fall, making low haptoglobin a key indicator of intravascular hemolysis. Hemolysis is also typically accompanied by elevated LDH, increased reticulocyte count, and elevated indirect bilirubin due to increased RBC breakdown and compensatory marrow response.


2. When Do You Answer a Haptoglobin Level?

Haptoglobin should be ordered when a clinical scenario suggests acute hemolysis, particularly when a patient develops sudden-onset anemia that cannot be explained by gastrointestinal bleeding or other obvious sources of blood loss. Features that point toward hemolysis include jaundice, dark urine, elevated LDH, or a rapid drop in hemoglobin without external bleeding. In board-style questions, a combination such as acute anemia + no GI bleeding = hemolysis, making haptoglobin part of the appropriate workup. The test helps confirm hemolysis and distinguish it from other causes of anemia.

Diagnostic Tests – Leukocyte Alkaline Phosphatase (LAP) Score

Leukocyte alkaline phosphatase (LAP) is an enzyme found inside mature white blood cells, particularly neutrophils. The LAP score reflects the activity level of this enzyme within these cells. When neutrophils are increased in number and functioning normally, the LAP score rises proportionately. This means that a high LAP score suggests that the elevated white blood cell count is due to a reactive, healthy response—such as an infection or inflammation—rather than a malignant or dysfunctional process. Conversely, when neutrophils are increased in number but function abnormally, the LAP score remains low.


LAP becomes an important diagnostic tool when there is concern about chronic myelogenous leukemia (CML) versus a leukemoid reaction. Both conditions can present with extremely high white blood cell counts dominated by neutrophils. However, in CML, the neutrophils are part of a malignant proliferation and do not function normally, leading to a low LAP score. A patient with CML often has additional findings such as a markedly enlarged spleen, causing left upper quadrant abdominal discomfort or early satiety. In contrast, a leukemoid reaction—typically triggered by infection or severe stress—produces very high white counts as part of a normal physiological response, resulting in a high LAP score. Therefore, LAP is the answer when distinguishing between these two conditions in the setting of significant neutrophilia.

Diagnostic Tests – Hemoglobin Electrophoresis

Hemoglobin electrophoresis is a diagnostic test used primarily to identify hemoglobinopathies—disorders in which the structure or production of hemoglobin is abnormal. It is the most sensitive and accurate method for detecting conditions such as sickle cell disease, sickle cell trait, and the various forms of thalassemia. Because it separates hemoglobin molecules based on their electrical charge, it allows for precise identification of both homozygous disease states and heterozygous carrier states (traits). This makes it an essential test when evaluating unexplained anemia, suspected genetic hemoglobin disorders, or when screening individuals from high-risk populations.


Clinically, several signs and symptoms may prompt a physician to order hemoglobin electrophoresis. In the context of sickle cell disease, patients may present with chronic leg ulcerations, recurrent bacterial infections—especially with Streptococcus pneumoniae or Haemophilus influenzae—or complications such as retinopathy, aseptic necrosis of the femoral head, osteomyelitis, and growth retardation. Splenomegaly may be present in children, while adults often develop autosplenectomy due to repeated infarctions. A strong family history and African-American ethnicity frequently raise suspicion. For sickle cell trait, testing is often prompted by asymptomatic individuals with a family member affected by sickle cell disease or by unexplained painless hematuria, which is a classic presentation.


In cases of thalassemia, the presentation can vary widely, from completely asymptomatic individuals to patients with severe disease. Findings such as microcytic anemia with normal iron studies, growth failure, hepatosplenomegaly, jaundice, and characteristic bony deformities may lead clinicians to order the test. Thalassemia is more common among individuals of Mediterranean, Middle Eastern, African, and Southeast Asian descent, so ancestry can also serve as an important clue. Overall, hemoglobin electrophoresis is ordered whenever there is suspicion of an inherited hemoglobin disorder based on symptoms, laboratory abnormalities, or patient background, and it plays a central role in confirming these diagnoses.

Diagnostic Tests: Osmotic Fragility Test​

Overview

The osmotic fragility test is a diagnostic laboratory test used primarily in hematology to identify red blood cell (RBC) membrane defects. It is most famously associated with hereditary spherocytosis, a condition in which RBCs lose membrane surface area and become spherical in shape. Because of their altered structure, these cells are more susceptible to destruction when exposed to certain osmotic conditions. The test helps clinicians confirm the diagnosis in patients presenting with hemolytic anemia and characteristic findings on peripheral smear.


How the Test Works

The osmotic fragility test evaluates how easily RBCs lyse when placed in hypotonic (dilute) saline solutions. Normal red cells have a biconcave shape, giving them a high surface area-to-volume ratio and allowing them to tolerate changes in osmotic pressure. In contrast, spherocytes—such as those seen in hereditary spherocytosis—have reduced membrane surface area, making them less flexible and less able to expand when water enters the cell.


When placed in increasingly hypotonic solutions, spherocytes absorb water more rapidly and lyse at higher saline concentrations than normal cells. The degree of hemolysis is measured by the amount of hemoglobin released into the solution. A higher-than-normal level of hemolysis at moderate hypotonicity indicates increased osmotic fragility.


When Osmotic Fragility Is the Best Answer

You should choose osmotic fragility testing when evaluating a patient with features suggestive of hereditary spherocytosis, particularly when the case includes:

• Hemolytic anemia, often chronic or recurrent
• Splenomegaly
• Spherocytes on peripheral blood smear
• Family history of similar episodes
• Pigmented (bilirubin) gallstones, which develop from chronic hemolysis

These key clinical clues, combined with laboratory findings, strongly support the use of osmotic fragility testing as part of the diagnostic work-up.

Diagnostic Tests – Methylmalonic Acid (MMA) Level

Methylmalonic acid (MMA) is a metabolic compound that accumulates in the body when vitamin B12 is deficient. Because MMA rises early in B12 deficiency, it is more sensitive than simply measuring serum vitamin B12 levels. In contrast, homocysteine levels increase in both vitamin B12 deficiency and folic acid deficiency, making homocysteine less specific. Therefore, MMA is a key diagnostic marker when evaluating macrocytic anemia and suspected B12 deficiency, especially when initial tests are inconclusive.


MMA testing becomes particularly important when a patient presents with macrocytic anemia, hypersegmented neutrophils, or clinical features suggestive of vitamin B12 deficiency—such as peripheral neuropathy, glossitis, or a history of malabsorption—but has a normal or borderline serum B12 level. In these situations, B12 levels may not accurately reflect tissue-level deficiency. Thus, when the clinical scenario strongly points toward B12 deficiency but the measured B12 level appears normal, the correct next diagnostic step is to order an MMA level to confirm or rule out early or functional B12 deficiency.

Diagnostic Tests– Lymph Node Biopsy

A lymph node biopsy is performed to determine whether lymph node enlargement is due to infection, malignancy, or another underlying condition. The choice between a needle biopsy and an excisional biopsy depends entirely on the clinical suspicion and the characteristics of the lymph node. Proper selection is essential because certain conditions require specific types of tissue sampling to achieve an accurate diagnosis.


A needle biopsy is the correct choice when an infectious cause of lymphadenopathy is suspected. Infections such as tuberculosis, fungal infections, or bacterial infections (including Staphylococcus) can be diagnosed using needle aspiration because this method provides enough material for microbiologic studies. Clinically, infectious lymph nodes are often warm, tender, red, and sometimes fluctuant, reflecting inflammation. Because diagnosing infection does not require assessing the full architecture of the lymph node, a needle biopsy is usually sufficient.


An excisional biopsy is the best and most accurate test when lymphoma is suspected. Lymphoma requires examination of the complete lymph node architecture, which cannot be obtained through a needle biopsy. In fact, using a needle biopsy to diagnose lymphoma is a frequent wrong answer in exams because individual lymphocytes can appear normal on cytology, leading to missed diagnoses. Lymph nodes involved in lymphoma are typically nontender, firm, and not warm or red, distinguishing them from infectious nodes. When these features are present, an excisional biopsy is the appropriate diagnostic test.

​Diagnostic Tests – Wolff–Parkinson–White (WPW) Syndrome

1. Disease Suggested by This EKG

The EKG presented is most consistent with Wolff–Parkinson–White (WPW) syndrome, a classic ventricular pre-excitation disorder. In WPW, an abnormal electrical pathway—typically the Bundle of Kent—allows impulses to bypass the AV node and activate part of the ventricles earlier than normal. This early depolarization produces the distinctive EKG signature of the condition and forms the basis for the arrhythmias often associated with WPW.

2. EKG Characteristics Leading to the Diagnosis

Two hallmark EKG findings point strongly toward WPW: a short PR interval and a delta wave, which appears as a slurred upstroke at the beginning of the QRS complex. The shortened PR interval reflects accelerated conduction from the atria to the ventricles through the accessory pathway. The delta wave represents the slow, pre-excited portion of the ventricles being activated prematurely. Together, these findings reveal that part of ventricular tissue is being depolarized outside the normal AV nodal route, confirming the presence of a pre-excitation syndrome.


3. Expected Clinical Case Features Accompanying This EKG

The clinical presentation accompanying this EKG typically involves paroxysmal supraventricular tachycardia (SVT) due to reentry involving both the AV node and the accessory pathway. Patients often experience sudden bursts of rapid heartbeat, palpitations, shortness of breath, or dizziness. Importantly, the clinical vignette may describe worsening of the tachycardia after administration of AV nodal–blocking medications, such as calcium channel blockers or digoxin. These medications reduce AV nodal conduction, unintentionally forcing more impulses down the accessory pathway and potentially accelerating ventricular rates to dangerous levels. Patients may alternate between SVT and episodes of wide-complex tachycardia if antidromic conduction is involved.


4. Pathophysiology Behind the EKG Findings and Disease Mechanism

At the core of WPW is an accessory conduction tract that forms a shortcut between the atria and ventricles, bypassing the physiological delay imposed by the AV node. Because the AV node acts as the normal gatekeeper that slows conduction, bypassing it allows impulses to reach and depolarize ventricular tissue prematurely. This results in the delta wave and shortened PR interval. The presence of this alternate pathway also creates conditions for reentrant circuits: impulses may travel down one route and back up the other, triggering rapid, repetitive activation of the cardiac chambers. These reentrant loops explain the abrupt onset and offset of tachyarrhythmias and, in severe cases—especially during atrial fibrillation—can lead to dangerously fast ventricular responses and even ventricular fibrillation.